Data / Drug companies / Neuromuscular Blocker
Neuromuscular Blocker drugs: 5 drugs from 11 companies in the FDA NDC directory
Neuromuscular Blocker is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 28 products in this class from 11 companies, covering 5 drugs by generic name. The main marketing category is biologics (BLA), and the newest product started marketing on March 20, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 11Companies
- 28Products
- 5Drugs by generic name
Drugs in the Neuromuscular Blocker class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Botulinum toxin type a | 4 | 3 |
| Incobotulinumtoxina | 8 | 2 |
| Onabotulinumtoxina | 5 | 2 |
| Letibotulinumtoxina-wlbg | 2 | 1 |
| Prabotulinum toxin type a | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| BioActive Nutritional, Inc. | 7 | liquid | Unapproved homeopathic products | March 20, 2025 |
| Merz Pharmaceuticals, LLC | 5 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 20, 2015 |
| Allergan, Inc. | 4 | injection, powder, lyophilized, for solution | Biologics (BLA) | January 11, 2010 |
| Merz North America, Inc. | 3 | injection, powder, lyophilized, for solution | Biologics (BLA) | August 1, 2011 |
| Hugel, Inc. | 2 | injection, powder, lyophilized, for solution | Biologics (BLA) | July 30, 2024 |
| Ipsen Biopharmaceuticals, Inc. | 2 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 2, 2009 |
| Deseret Biologicals, Inc. | 1 | liquid | Unapproved homeopathic products | June 28, 2021 |
| Evolus, Inc. | 1 | powder | Biologics (BLA) | February 13, 2019 |
| Galderma Laboratories, L.P. | 1 | injection, powder, lyophilized, for solution | Biologics (BLA) | November 2, 2009 |
| Revance Therapeutics, Inc. | 1 | injection, powder, lyophilized, for solution | Biologics (BLA) | September 20, 2022 |
| Sportpharm LLC | 1 | injection, powder, lyophilized, for solution | Biologics (BLA) | December 15, 1989 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 19 | 67.9% |
| Liquid | 8 | 28.6% |
| Powder | 1 | 3.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.